ATE349223T1 - Pharmazeutische zubereitungen mit verbesserten oberflächeneigenschaften welche ein lungen surfactant und ein polymyxin enthalten - Google Patents

Pharmazeutische zubereitungen mit verbesserten oberflächeneigenschaften welche ein lungen surfactant und ein polymyxin enthalten

Info

Publication number
ATE349223T1
ATE349223T1 AT02004789T AT02004789T ATE349223T1 AT E349223 T1 ATE349223 T1 AT E349223T1 AT 02004789 T AT02004789 T AT 02004789T AT 02004789 T AT02004789 T AT 02004789T AT E349223 T1 ATE349223 T1 AT E349223T1
Authority
AT
Austria
Prior art keywords
polymyxin
contain
pharmaceutical preparations
surface properties
improved surface
Prior art date
Application number
AT02004789T
Other languages
English (en)
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27675681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE349223(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE349223T1 publication Critical patent/ATE349223T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02004789T 2002-03-01 2002-03-01 Pharmazeutische zubereitungen mit verbesserten oberflächeneigenschaften welche ein lungen surfactant und ein polymyxin enthalten ATE349223T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02004789A EP1340506B1 (de) 2002-03-01 2002-03-01 Pharmazeutische Zubereitungen mit verbesserten Oberflächeneigenschaften welche ein Lungen Surfactant und ein Polymyxin enthalten

Publications (1)

Publication Number Publication Date
ATE349223T1 true ATE349223T1 (de) 2007-01-15

Family

ID=27675681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02004789T ATE349223T1 (de) 2002-03-01 2002-03-01 Pharmazeutische zubereitungen mit verbesserten oberflächeneigenschaften welche ein lungen surfactant und ein polymyxin enthalten

Country Status (12)

Country Link
US (2) US20050203008A1 (de)
EP (3) EP1340506B1 (de)
AR (1) AR038642A1 (de)
AT (1) ATE349223T1 (de)
AU (1) AU2003210361A1 (de)
DE (1) DE60217060T2 (de)
DK (1) DK1340506T3 (de)
ES (1) ES2278823T3 (de)
PE (1) PE20030837A1 (de)
PT (1) PT1340506E (de)
SI (1) SI1340506T1 (de)
WO (1) WO2003074070A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0715095B8 (pt) * 2006-08-11 2021-05-25 Northern Antibiotics Oy derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i).
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
KR20120023663A (ko) * 2009-05-25 2012-03-13 키에시 파르마슈티시 엣스. 피. 에이. 폐 계면활성제 및 스테로이드를 포함하는 치료적 조합
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer
EA201692569A1 (ru) 2014-07-09 2017-05-31 Кселлия Фармасьютикалз Апс Полимиксины с низкой степенью замещения и композиции, их содержащие
KR102494511B1 (ko) 2014-10-03 2023-01-31 셀리아 파마슈티칼즈 에이피에스 흡입 장치
SG11201702717XA (en) 2014-10-03 2017-04-27 Xellia Pharmaceuticals Aps Compositions
CN104721509A (zh) * 2015-04-05 2015-06-24 四川双鑫生物科技有限公司 一种治疗小儿病毒性肺炎的汤剂药物及制备方法
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
EP1752161A3 (de) 2010-09-01
EP1480667B1 (de) 2006-12-06
US20050203008A1 (en) 2005-09-15
AR038642A1 (es) 2005-01-19
US20090170758A1 (en) 2009-07-02
AU2003210361A1 (en) 2003-09-16
ES2278823T3 (es) 2007-08-16
SI1340506T1 (sl) 2007-04-30
WO2003074070A1 (en) 2003-09-12
EP1340506A1 (de) 2003-09-03
DE60217060T2 (de) 2007-06-21
EP1340506B1 (de) 2006-12-27
DE60217060D1 (de) 2007-02-08
DK1340506T3 (da) 2007-05-07
EP1752161A2 (de) 2007-02-14
PT1340506E (pt) 2007-03-30
EP1480667A1 (de) 2004-12-01
PE20030837A1 (es) 2003-11-21

Similar Documents

Publication Publication Date Title
NO2024004I1 (no) insulin degludec
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
ATE435630T1 (de) Zwischenwirbelimplantat mit kalottenartigen gelenkflächen
LTC1641823I2 (lt) GLP-1 analogo sulieti baltymai
DE60316737D1 (de) Parallelstangenmechanismus und damit versehenes künstliches Gelenk
IL207953A0 (en) Gastrin - releasing peptide compounds and methods utilizing the same
NO2009013I2 (no) Laropiprant eller et farmasøytisk akseptabelt saltderav
ATE460169T1 (de) Pharmazeutische formulierung mit lanthanum- verbindungen
DE60324239D1 (de) Beutel und dessen Herstellungsverfahren
IL172507A0 (en) New biological entities and the pharmaceutical or diagnostic use thereof
ATE334656T1 (de) Flüssige pharmazeutische zusammensetzung
DE60311223D1 (de) Aktuator und dessen Herstellungsverfahren
ATE317679T1 (de) Saugfähiges produkt mit verbessertem sitz
ATE305762T1 (de) Saugfähiges produkt mit verbessertem sitz
ATE318125T1 (de) Saugfähiges produkt mit verbessertem sitz
ATE349223T1 (de) Pharmazeutische zubereitungen mit verbesserten oberflächeneigenschaften welche ein lungen surfactant und ein polymyxin enthalten
EP1645277A4 (de) Stabile gefriertrocknende medizinische tetrodotoxin-zubereitung
DK1462455T3 (da) Ser-Ser-Ser-Arg-peptid samt medicinske anvendelser deraf
ATE318126T1 (de) Saugfähiges produkt mit verbessertem sitz
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE434435T1 (de) Pharmazeutische zubereitungen enthaltend modafinil
DE10291905D2 (de) Pharmazeutische Zusammensetzung
DE10107261B4 (de) Pharmazeutische Zusammensetzung
DE60305642D1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1340506

Country of ref document: EP